Cognitive Training for Face Blindness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new cognitive training program aimed at helping individuals with face blindness, also known as developmental prosopagnosia, improve their face recognition abilities. The program, called repetition lag training, is designed to enhance these skills. Participants will either engage in the new training or join a waitlist control group for comparison. It suits adults who have consistently struggled with recognizing faces in everyday life but do not have major neurological conditions. As an unphased trial, this study provides a unique opportunity to contribute to research that could lead to new strategies for improving face recognition.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have ADHD, you must have been on the same medication for the past 6 months to participate.
What prior data suggests that this cognitive training intervention is safe?
Research has shown that Repetition Lag Training safely improves facial recognition. This training employs spaced repetition, spreading learning sessions over time to enhance memory. Previous studies have reported no harmful effects from this training. It is designed to assist individuals with developmental prosopagnosia, a condition that makes recognizing faces difficult. As this study is not part of the typical clinical trial phases, it indicates that the training is not a new drug but a method likely considered safe.12345
Why are researchers excited about this trial?
Researchers are excited about the cognitive training for face blindness because it introduces a novel way to tackle the condition through Repetition Lag Training. Unlike traditional approaches, which might focus on compensatory strategies or therapy for coping with prosopagnosia, this training targets the brain's processing patterns directly. By emphasizing the timing and sequence of recognizing faces, it aims to improve recognition abilities at a cognitive level. This innovative approach could provide a more effective and long-lasting solution for individuals struggling with face blindness.
What evidence suggests that this cognitive training is effective for face blindness?
Research has shown that repetition lag training, one of the treatments in this trial, can improve memory and the ability to recognize faces. This training uses spaced repetition, spreading learning sessions over time, to enhance memory and recognition skills. Studies have found positive results, particularly for individuals with developmental prosopagnosia, or face blindness, who experience milder perception issues. Repetition lag training has also proven helpful for other memory problems, such as those seen after a stroke, suggesting its effectiveness for face recognition difficulties. These findings support the idea that this training can help individuals with face blindness recognize faces better. Participants in this trial may receive holistic face training combined with repetition lag training, while others will be in a waitlist control group.25678
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with Developmental Prosopagnosia, a condition where they have lifelong difficulties recognizing faces, impacting daily life. They must perform poorly on specific face recognition tests. Excluded are those with substance dependence, significant neurological disorders, sensory impairments, severe psychiatric conditions or recent participation in other interventions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cognitive training intervention targeting face recollection, including repetition lag training
Follow-up
Participants are monitored for improvements in face recognition abilities
What Are the Treatments Tested in This Trial?
Interventions
- Repetition Lag Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Harvard Medical School
Lead Sponsor
Harvard Medical School (HMS and HSDM)
Lead Sponsor
Boston VA Research Institute, Inc.
Lead Sponsor